Vinci Pharmaceuticals
PrivateLast Round
Series A
Oct 8, 2026
Total Funding Raised
$16.5M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Vinci Pharmaceuticals operates in Healthcare & Life Sciences and is based in Avon-by-the-Sea, New Jersey. Its latest recorded funding round was a Series A round in October 2026.
Vinci Pharmaceuticals is a specialty ophthalmic pharmaceutical company that develops innovative, needle-free drug delivery platforms for the treatment of retinal diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vinci Pharmaceuticals Comparables
Compare Vinci Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Re-Vana Therapeutics | 83% | |
| Ripple Therapeutics | 82% | |
| Targeted Therapy Technologies, LLC | 79% |
For institutional investors. Book with your work email.
Vinci Pharmaceuticals Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Vinci Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MintPharma Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 8, 2026
Raised $8M led by MintPharma Capital.
- May 13, 2026
Monthly visitors increased 667% MoM, from 48 to 368.
For institutional investors. Book with your work email.
Vinci Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Vinci Pharmaceuticals's valuation, stock price, and market status.
Is Vinci Pharmaceuticals a public or private company?
Vinci Pharmaceuticals is a private company.
What is the current stock price of Vinci Pharmaceuticals?
Vinci Pharmaceuticals is a private company, so its shares have no public market price. Caplight tracks Vinci Pharmaceuticals's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Vinci Pharmaceuticals worth (valuation)?
Valuation information for Vinci Pharmaceuticals is not publicly available.
Can I buy Vinci Pharmaceuticals stock?
Vinci Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Vinci Pharmaceuticals's last funding round?
Vinci Pharmaceuticals's most recent funding round was Series A on October 8, 2026.
Who are the main investors in Vinci Pharmaceuticals?
Key investors in Vinci Pharmaceuticals include MintPharma Capital.
Will Vinci Pharmaceuticals IPO soon?
No public IPO plans have been announced for Vinci Pharmaceuticals.
How can I track Vinci Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades in Vinci Pharmaceuticals's shares on secondary markets.